Cellular protein shredders for the fight against cancer
Study by the Universities of Bonn and Ulm investigates how a cellular mechanism can be used for other purposesCredit: © ...
Study by the Universities of Bonn and Ulm investigates how a cellular mechanism can be used for other purposesCredit: © ...
Creation of world's fastest cancer onset mouse modelCredit: Kobe University Joint research between Kobe University and National Hospital Organization Kyushu ...
Credit: Advanced Accelerator Applications Saint-Genis-Pouilly, France, March 25, 2020 - Advanced Accelerator Applications S.A. (AAA), a Novartis company, today announced ...
Los Angeles- and Dallas-based cancer centers join alliance of leading medical institutions that create guidelines which define optimal cancer management ...
Credit: Scott Leighow, Penn State Whether it is a drug-resistant strain of bacteria, or cancer cells that no longer react ...
Credit: Image courtesy of Mohammad Heiranian CHAMPAIGN, Ill. -- Graphene-based biosensors could usher in an era of liquid biopsy, detecting ...
Penn researchers publish proof-of-concept to use alternative immune cells to target cancerCredit: Penn Medicine PHILADELPHIA - Chimeric antigen receptor (CAR) ...
Study in mouse, human cells suggests unique anti-cancer properties of such a therapyCredit: Sturgeon Lab Immunotherapy that involves treating cancer ...
Oncotarget Volume 11, Issue 11 reported that relapsed APL, particularly in the high-risk subset of patients, remains an important clinical ...
Oncotarget Volume 11, Issue 11 reported that at clinical progression, 64 EGFR T790M plasma positive patients were subjected to second ...
Oncotarget Volume 11, Issue 11 reported that in order to understand the molecular mechanism of the dependency in MM, the ...
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, ...
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, ...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, March 19, 2020--A new study has shown a novel peptide antagonist, ...
Credit: Barth van Rossum, FMP A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) ...
Open-label Phase II study at MD Anderson reports on four cancer typesCredit: The University of Texas MD Anderson Cancer Center ...
Credit: Walter and Eliza Hall Institute, Australia A revolutionary new technology has been applied to reveal the inner workings of ...
The cover for issue 11 of Oncotarget features Figure 6, "Effects of AZD8186 in combination with anti-PD1 on syngeneic models," ...
Experts from Seattle Cancer Care Alliance share lessons learned from early experiences treating people with cancer during COVID-19 outbreak via ...
Credit: Marc Healy, UZH Colorectal carcinoma (CRC), the most common form of intestinal cancer, is the second leading cause of ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.